Patents by Inventor Tabea KRÄFT

Tabea KRÄFT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE CELL DEATH-INDUCING ENZYME SYSTEM
    Publication number: 20220370555
    Abstract: The invention relates to a fusion protein containing a selective cell death-inducing enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use.
    Type: Application
    Filed: March 13, 2018
    Publication date: November 24, 2022
    Applicant: SIT Biotech GmbH
    Inventors: Sylvain TOUREL, Tabea KRÄFT